Contemporary Bloodletting in Cardiac Surgical Care

Slides:

Advertisements

Similar presentations

Factors Influencing Hospital Length of Stay After Robotic Totally Endoscopic Coronary Artery Bypass Grafting Jeffrey D. Lee, MD, Nikolaos Bonaros, MD,

Advertisements

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,

What Predicts Long-Term Survival After Heart Transplantation

Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Clinical Outcomes in Patients With Prolonged Intensive Care Unit Length of Stay After Cardiac Surgical Procedures Ansar Hassan, MD, PhD, Curtis Anderson,

Unusual Gastrointestinal Bleeding After Sutureless Aortic Valve Replacement: A Word of Caution Jules Iquille, MD, Joseph Nader, MD, Eric Colpart, MD,

Amit Iyengar, Christopher N. Scipione, MD, Parth Sheth, Richard G

Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S

Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both? Alessandro Vivacqua, MD, Colleen G. Koch, MD,

The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both? Gabriel Loor, MD, Jeevanantham Rajeswaran, PhD, Liang Li, PhD, Joseph F.

Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.

Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery

Process improvement in cardiac surgery: Development and implementation of a reoperation for bleeding checklist Gabriel Loor, MD, Alessandro Vivacqua,

Randal S. Blank, MD, PhD, Christoph Hucklenbruch, MD, Kelly K

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

A Comparison of Length of Stay, Readmission Rate, and Facility Reimbursement After Lobectomy of the Lung Richard K. Freeman, MD, MBA, J. Russell Dilts,

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients Faraz Kerendi, MD, John D. Puskas,

Lu Dai, MSc, Stephanie L. Mick, MD, Keith R. McCrae, MD, Penny L

Transfusion Increases the Risk for Vasoplegia After Cardiac Operations

Red Blood Cell Storage: How Long Is Too Long?

Gabriel Loor, MD, Colleen G. Koch, MD, MS, MBA, Joseph F

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Ni Zhang, MD, Qin-zi Xu, MD, Xiang-ning Fu, MD, Wei Sun, MD

William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E

Factors Influencing Hospital Length of Stay After Robotic Totally Endoscopic Coronary Artery Bypass Grafting Jeffrey D. Lee, MD, Nikolaos Bonaros, MD,

Richard S. D’Agostino, MD, Jeffrey P

Who Do You Say You Are? The Annals of Thoracic Surgery

Relationship Between Antiinflammatory Cytokine Interleukin-10 and Lactate Concentrations in Neonates Undergoing the Arterial Switch Operation Kyrylo.

Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery Lyndsey J. Bowman, Walter E.

Damien J. LaPar, MD, MS, James M. Isbell, MD, MSCI, Daniel P

The Relationship Between Hospital Surgical Case Volumes and Mortality Rates in Pediatric Cardiac Surgery: A National Sample, 1988–2005 Karl F. Welke,

Use of Amiodarone After Major Lung Resection

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Risks and Predictors of Blood Transfusion in Pediatric Patients Undergoing Open Heart Operations Andrea Székely, MD, PhD, Zsuzsanna Cserép, MD, Erzsébet.

Farhang Yazdchi, MD, MS, Colleen G

Optimal Plasma Transfusion in Patients Undergoing Cardiac Operations With Massive Transfusion Michael A. Mazzeffi, MD, MPH, Evan Chriss, MD, Kathryn.

Zoe K. McQuilten, MBBS, Nick Andrianopoulos, MBBS, MBiostat, Erica M

Joseph Rabin, MD, Timothy Meyenburg, DNP, CRNP, Ashleigh V

Joshua W. Salvin, MD, MPH, Mark A. Scheurer, MD, Peter C

Terry Shih, MD, Justin B. Dimick, MD, MPH

Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Ruyun Jin, MD, Anthony P. Furnary, MD, Stephanie C. Fine, MA, Eugene H

Editorial Board, January 2010

The diabetes epidemic and its effect on cardiac surgery practice

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Eeva-Maija.

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Aaron J. Lindsay, MD, Meng Xu, MS, Daniel I. Sessler, MD, Eugene H

Bobby Yanagawa, MD, PhD, Rodolfo V

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Is Early Too Early? Effect of Shorter Stays After Bypass Surgery

Very Prolonged Stay in the Intensive Care Unit After Cardiac Operations: Early Results and Late Survival Shuli Silberman, MD, Daniel Bitran, MD, Daniel.

Michael W. A. Chu, MD, Steve R. Wilson, BS, Richard J

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell,

Minimal access aortic valve replacement: effects on morbidity and resource utilization Nicolas Doll, MD, Michael A Borger, MD, PhD, Joerg Hain, Jan Bucerius,

Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation Justin M. Schaffer, MS, George J. Arnaoutakis,

Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost Michael J Ray, PhD, Mark F O’Brien

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Mark I. Block, MD The Annals of Thoracic Surgery

The Impact of New Technology on Cardiothoracic Surgical Practice

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Presentation transcript:

Contemporary Bloodletting in Cardiac Surgical Care Colleen G. Koch, MD, MS, Edmunds Z. Reineks, MD, PhD, Anne S. Tang, MS, Eric D. Hixson, PhD, MBA, Shannon Phillips, MD, Joseph F. Sabik, MD, J. Michael Henderson, MD, Eugene H. Blackstone, MD The Annals of Thoracic Surgery Volume 99, Issue 3, Pages 779-784 (March 2015) DOI: 10.1016/j.athoracsur.2014.09.062 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Algorithm for phlebotomy volume. (CVICU=cardiovascular intensive care unit.) The Annals of Thoracic Surgery 2015 99, 779-784DOI: (10.1016/j.athoracsur.2014.09.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Phlebotomy volume by 25th, 50th, 75th, and 100th percentile groups, and percentage of patients transfused with red blood cells (RBC), cryoprecipitate (Cryo), fresh frozen plasma (FFP), and platelets. Transfusion requirements increase in a dose-dependent manner with increasing phlebotomy volume. The Annals of Thoracic Surgery 2015 99, 779-784DOI: (10.1016/j.athoracsur.2014.09.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Hospital length of stay and cumulative median phlebotomy volume. The numbers above each bar represent the number of patients with that length of stay and median phlebotomy volume. As length of stay increases, the median phlebotomy volume increases in a dose-dependent manner. The Annals of Thoracic Surgery 2015 99, 779-784DOI: (10.1016/j.athoracsur.2014.09.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Hospital length of stay, median phlebotomy volume, and percentage of patients transfused. The size of the bubble is proportional to the percentage of transfused red blood cells. The figure demonstrates that longer hospital stay was associated with greater median phlebotomy volume and a greater percentage of patients requiring red blood cell transfusion. (A) Horizontal axis extends to 275 days. (B) Horizontal axis extends to only 40 days, which illustrates the near linear relationship. The Annals of Thoracic Surgery 2015 99, 779-784DOI: (10.1016/j.athoracsur.2014.09.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions